Evaluation of the Novel CE-IVD-Marked Multiplex PCR QIAstat-Dx Meningitis/Encephalitis Panel
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; 13 of the 21 sources its claims cite were checked for support.
Abstract
The diagnosis of infectious meningitis and encephalitis relies mostly on specific PCR and culturing methods, but commercial syndromic panel assays are bringing a change in diagnostics. With multiplexed analysis, the identification of the pathogen is potentially faster, and less sample material is needed. The novel QIAstat-Dx meningitis/encephalitis panel assay is intended for the rapid identification of pathogens from cerebrospinal fluid for suspected central nervous system (CNS) infection, which is a life-threatening condition and difficult to diagnose. We studied the performance of this panel assay using patient samples and dilution series of selected viruses. The evaluation data for this novel meningitis/encephalitis panel assay are useful for other clinical laboratories and organizations using or considering using this test.
Overview
CoChat Summary
TL;DR
This retrospective single-center study evaluated the QIAstat-Dx meningitis/encephalitis (QIA/ME) multiplex PCR panel against the BioFire FilmArray ME panel and reference methods using frozen residual CSF samples, plus HSV-1/HSV-2/VZV dilution series. QIA/ME and FA/ME were broadly similar on patient samples, but QIA/ME showed some false negatives and poorer performance than FA/ME for herpesvirus dilution series.
Key findings
- In patient samples, QIA/ME had positive percent agreement/negative percent agreement of 100% for all included pathogens except *S. pneumoniae*; for *S. pneumoniae*, NPA was 98.7% because one sample was positive by the diagnostic reference method and QIA/ME but negative by FA/ME.
- Compared with the diagnostic reference methods, the overall PPA was 95.1% for QIA/ME and 93.8% for FA/ME.
- For herpesvirus dilution series, real-time PCR methods with separate extraction were the most sensitive, and FA/ME performed better than QIA/ME overall.
- QIA/ME had 3 errors and 4 failed results in 108 runs for a 6.5% total error rate; FA/ME had 0% error rate in 115 runs.
- External quality control samples from QCMD showed 100% consistency with the expected results for both QIA/ME and FA/ME.
Methods
- Retrospective single-center evaluation using frozen residual CSF samples sent to Helsinki University Hospital Laboratory from 2017 to 2022; 63 positive CSF samples (by reference method) and 16 clinical samples negative by FA/ME were included.
- QIA/ME was run in parallel with FA/ME; results were compared with reference PCR methods or cultivation, and agreements were calculated as PPA and NPA using the study’s defined formulas.
- A separate analytical comparison used HSV-1, HSV-2, and VZV dilution series (1:102 to 1:107) tested across six PCR methods, and QCMD 2021 CNS I external quality assessment samples were also tested.
Limitations
- The paper states this was a retrospective single-center study using frozen residual CSF samples, and that samples were preselected based on availability; it says this does not represent real-life laboratory practice where most CSF samples are negative.
- The study had a small sample size, with some bacterial targets absent entirely and others represented by only a few samples; it also had a narrow Cq range and lacked more challenging low-viral-load samples.
- Evident from the text: several comparisons are based on very small numbers for specific pathogens (for example, only two HHV-6-positive samples), which limits precision of those pathogen-specific estimates.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 0 Not valid · 4 Not checked · 56 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In this study, with a relatively small sample size, the positive and negative percent agreements of QIA/ME and FA/ME (Tables 3 to 5) were slightly better than the specificity and sensitivity values seen in previous studies evaluating FA/ME (17–24).”
§ Evaluation of the Novel CE-IVD-Marked Multiplex PCR QIAstat-Dx Meningitis/Encephalitis Panel > DISCUSSION
What the sources say
- Supportedcites [17] Vetter P, Schibler M, Herrmann JL, Boutolleau D. 2020. Diagnostic challenges of central nervous system infection: extensive multiplex panels versus stepwise guided approach. Clin Microbiol Infect 26: 706– 712. doi: 10.1016/j.cmi.2019.12.013. 31899336 source
The ‘Multiplex PCR panels: analytical and clinical performances’ section reports performance figures from earlier FilmArray ME evaluations, including 85.6% positive agreement and sensitivity estimates for bacteria and viruses (page unavailable). The citation supports the prior-performance comparison; the small sample size, QIA/ME results, and judgment that the current results were ‘slightly better’ are the citing authors’ own findings and comparison. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [18] Tansarli GS, Chapin KC. 2020. Diagnostic test accuracy of the BioFire FilmArray meningitis/encephalitis panel: a systematic review and meta-analysis. Clin Microbiol Infect 26: 281– 290. doi: 10.1016/j.cmi.2019.11.016. 31760115 source
- Supportedcites [19] Leber AL, Everhart K, Balada-Llasat J-M, Cullison J, Daly J, Holt S, Lephart P, Salimnia H, Schreckenberger PC, DesJarlais S, Reed SL, Chapin KC, LeBlanc L, Johnson JK, Soliven NL, Carroll KC, Miller J-A, Dien Bard J, Mestas J, Bankowski M, Enomoto T, Hemmert AC, Bourzac KM. 2016. Multicenter evaluation of BioFire FilmArray meningitis/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. J Clin Microbiol 54: 2251– 2261. doi: 10.1128/JCM.00730-16. 27335149 PMC5005480 source
The cited paper is a prior evaluation of the FilmArray ME Panel. Its Results (Table 3) report sensitivity/PPA and specificity/NPA values for the panel, which is the part of the citing sentence supported by this citation. The comparison with QIA/ME and the small sample size describe the citing study, not this source. (LLM, conf=0.90)
- Supportedcites [20] Trujillo-Gómez J, Tsokani S, Arango-Ferreira C, Atehortúa-Muñoz S, Jimenez-Villegas MJ, Serrano-Tabares C, Veroniki A-A, Florez ID. 2022. Biofire FilmArray meningitis/encephalitis panel for the aetiological diagnosis of central nervous system infections: a systematic review and diagnostic test accuracy meta-analysis. eClinicalMedicine 44: 101275. doi: 10.1016/j.eclinm.2022.101275. 35198914 PMC8851290 source
The citation supports the reference to previous FA/ME accuracy findings, not the citing authors’ results for their own sample. In Results > Main results (page unavailable), the meta-analysis reports pooled FA/ME sensitivity and specificity from 15–16 studies, providing the prior-study values used for comparison. (LLM, conf=0.87)
- Supportedcites [21] Fleischer E, Aronson PL. 2020. Rapid diagnostic tests for meningitis and encephalitis—BioFire. Pediatr Emerg Care 36: 397– 401. doi: 10.1097/PEC.0000000000002180. 32740268 PMC7703746 source
The Evidence section (page unavailable) reports sensitivity and specificity values from previous evaluations of the BioFire FilmArray ME panel, including pooled estimates of 90.2% and 97.7%. The citing paper supplies its own QIA/ME and FA/ME agreement results; this source supports the earlier FA/ME values used for comparison. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [22] Liesman RM, Strasburg AP, Heitman AK, Theel ES, Patel R, Binnicker MJ. 2018. Evaluation of a commercial multiplex molecular panel for diagnosis of infectious meningitis and encephalitis. J Clin Microbiol 56: e01927-17. doi: 10.1128/JCM.01927-17. 29436421 PMC5869843 source
- Supportedcites [23] Lindström J, Elfving K, Lindh M, Westin J, Studahl M. 2022. Assessment of the FilmArray ME panel in 4199 consecutively tested cerebrospinal fluid samples. Clin Microbiol Infect 28: 79– 84. doi: 10.1016/j.cmi.2021.05.017. 34015534 source
The citation is offered for the previous FA/ME sensitivity and specificity values, not for the citing authors’ QIA/ME results or their comparison. The source reports FilmArray ME panel sensitivity and specificity by pathogen in ME panel performance (p. 3), providing the earlier values used for comparison. (LLM, conf=0.92)
- Supportedcites [24] Pfefferle S, Christner M, Aepfelbacher M, Lütgehetmann M, Rohde H. 2020. Implementation of the FilmArray ME panel in laboratory routine using a simple sample selection strategy for diagnosis of meningitis and encephalitis. BMC Infect Dis 20: 170. doi: 10.1186/s12879-020-4904-4. 32087681 PMC7036261 source
The Results—Clinical performance section reports FA/ME sensitivity of 96.30% and specificity of 96.58% in 171 samples, providing a previous-study benchmark for the citing paper’s comparison. The QIA/ME and FA/ME agreements in the citing paper are identified as its own results (Tables 3–5), not findings attributed to this source. (LLM, conf=0.89)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The FA/ME error rate was 0% (total of 115 samples run).”
§ Evaluation of the Novel CE-IVD-Marked Multiplex PCR QIAstat-Dx Meningitis/Encephalitis Panel > RESULTS > User experience and device functionality of QIA/ME.
plainn = 115- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“FA/ME seemed to perform even better than the Simplexa HSV 1&2 direct assay, especially with HSV-2 dilutions (Table 6).”
§ Evaluation of the Novel CE-IVD-Marked Multiplex PCR QIAstat-Dx Meningitis/Encephalitis Panel > RESULTS > Results of herpesvirus dilutions.
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this study, QIA/ME was unable to identify HSV-1-, HSV-2-, and HHV-6-positive samples (one each).”
§ Evaluation of the Novel CE-IVD-Marked Multiplex PCR QIAstat-Dx Meningitis/Encephalitis Panel > DISCUSSION
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The positive percent agreement (PPA) and negative percent agreement (NPA) of QIA/ME were 100% for all included pathogens except S. pneumoniae (Table 2).”
§ Evaluation of the Novel CE-IVD-Marked Multiplex PCR QIAstat-Dx Meningitis/Encephalitis Panel > RESULTS > Results for patient samples.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
22 more claims
Create a free account to see all 64 claims and every source verdict.
- Probably not a substantial claim. 14
- It may state two separate claims as one. 32
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For viral pathogens, identification using singleplex real-time PCR methods has demonstrated the highest sensitivity and specificity [2,4,5].”
From Performance Evaluation of Multiplex Molecular Syndromic Panel vs. Singleplex PCR for Diagnosis of Acute Central Nervous System Infections (2025) · cites this paper as [5]
Experimental — accuracy not yet measured
Citations
Cites
Manual of Clinical Microbiology
(2011) · Wiley eBooks · doi:10.1128/9781555816728 · Cited by 1,003
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930
ESCMID guideline: diagnosis and treatment of acute bacterial meningitis
van de Beek, D., Cabellos, C., Dzupova, O., Esposito, S., Klein, M., Kloek, A. T., Leib, S. L., Mourvillier, B., Ostergaard, C., Pagliano, P., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.007 · Cited by 919
Whitley, R. J., Soong, S.-J., Dolin, R., Galasso, G. J., Ch'ien, L. T., Alford, C. A., & the Collaborative Study Group (1977) · New England Journal of Medicine · doi:10.1056/nejm197708112970601 · Cited by 711
Leber, A. L., Everhart, K., Balada-Llasat, J.-M., Cullison, J., Daly, J., Holt, S., Lephart, P., Salimnia, H., Schreckenberger, P. C., DesJarlais, S., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00730-16 · Cited by 609 · cited 1×
“previously been linked mainly to false-positive results (18, 19, 23).”
BackgroundTyler, K. L. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1708714 · Cited by 275
Tansarli, G. S., & Chapin, K. C. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.016 · Cited by 263
Koskiniemi, M., Rantalaiho, T., Piiparinen, H., von Bonsdorff, C.-H., Färkkilä, M., Järvinen, A., Kinnunen, E., Koskiniemi, S., Mannonen, L., Muttilainen, M., et al. (2001) · Journal of Neurovirology · doi:10.1080/135502801753170255 · Cited by 224
Self-citationLiesman, R. M., Strasburg, A. P., Heitman, A. K., Theel, E. S., Patel, R., & Binnicker, M. J. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01927-17 · Cited by 186
Kohil, A., Jemmieh, S., Smatti, M. K., & Yassine, H. M. (2021) · Archives of Virology · doi:10.1007/s00705-020-04891-1 · Cited by 164
Cited by
Candel, F. J., Salavert, M., Cantón, R., del Pozo, J. L., Galán‐Sánchez, F., Navarro, D., Rodríguez, A. H., Rodríguez, J. C., Rodríguez-Aguirregabiria, M., Suberviola, B., et al. (2024) · Critical Care · doi:10.1186/s13054-024-05224-3 · Cited by 81
Distinguishing community-acquired bacterial and viral meningitis: Microbes and biomarkers
Ivaska, L., Herberg, J., & Sadarangani, M. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.01.010 · Cited by 28
An Assessment of a New Rapid Multiplex PCR Assay for the Diagnosis of Meningoencephalitis
Cuesta, G., Puerta-Alcalde, P., Vergara, A., Roses, E., Bosch, J., Casals-Pascual, C., Soriano, A., Marcos, M. Á., Sanz, S., & Vila, J. (2024) · Diagnostics · doi:10.3390/diagnostics14080802 · Cited by 17
Boers, S. A., van Houdt, R., van Sorge, N. M., Groot, J., van Aarle, Y., van Bussel, M. J. A. W. M., Smit, L. F. E., Wessels, E., & Claas, E. C. J. (2024) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-024-04751-9 · Cited by 12
Milburn, J., Suresh, R., Doyle, R., & Jarvis, J. N. (2024) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2024.2317414 · Cited by 12
Metadata
- Authors
- Humisto, A., Antikainen, J., Holma, T., Jarva, H., Toivonen, A., Loginov, R., & Mannonen, L.
- Affiliations
- University of Helsinki (FI)
- Corresponding author
- Humisto, Anu
- Venue
- Microbiology Spectrum
- Publisher
- American Society for Microbiology
- Published
- 2023-06-15
- Volume
- 11
- Issue
- 3
- Pages
- e0514422-e0514422
- ISSN
- 2165-0497 (ISSN-L)
- PMC
- PMC10269741
- OpenAlex
- W4365136212
- Cited by
- 21
- References
- 32
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 9
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Microbiology Spectrum (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Työväentutkimus Vuosikirja (submittedVersion)
- Funders
- University of Helsinki Hospital laboratory, internal funding
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- multiplex PCR, meningitis, encephalitis, cerebrospinal fluid, central nervous system infection, virus detection, assay evaluation
- MeSH terms
- Bacteria, Encephalitis, Humans, Meningitis, Viruses, Multiplex Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of the Novel CE-IVD-Marked Multiplex PCR QIAstat-Dx Meningitis/Encephalitis Panel. https://app.cochat.ai/papers/10.1128/spectrum.05144-22
- The paper
- Humisto, A., Antikainen, J., Holma, T., Jarva, H., Toivonen, A., Loginov, R., & Mannonen, L. (2023). Evaluation of the Novel CE-IVD-Marked Multiplex PCR QIAstat-Dx Meningitis/Encephalitis Panel. Microbiology Spectrum. https://doi.org/10.1128/spectrum.05144-22
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.